Near Patient Molecular solutions Market

Near Patient Molecular solutions Market - Size,
Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Near patient molecular solution, also called point-of-care diagnosis, is a technology that helps
diagnose and monitor health at the convenience of the patient. There are various innovations in
healthcare such as basic health monitoring smartphone apps, wearable devices, and biosensors,
which provide ease to patient in monitoring their health. The motive is to provide patients with easy
access to testing solutions, with quick turnaround time and accurate results as opposed to that
offered by conventional lab-based tests.
Request Sample Copy of Research Report:
Increasing incidence of diseases such as cardiac disorders and diabetes in developing countries,
growing preference for home-based point-of-care devices, advancements in technology, and wide
availability of easy to use devices are spurring growth of the near patient molecular solution market.
According to the institute for Health Metrics and Evaluation (IHME), the number of deaths due to
cardiovascular diseases worldwide increased by 41% between 1990 and 2013, from 12.3 million to
17.3 million deaths. South Asia experienced the largest increase in total deaths, with 1.8 million more
deaths in 2013 than in 1990—an alarming increase of 97%.
Quick turnaround times of Near Patient Molecular Solutions a boon for Hospitals and
Private Clinics
End users of near patient molecular solution or POC devices include hospitals, homecare,
research laboratories and diagnostic laboratories. Use of near patient molecular solutions
provides fast turnaround times for physicians at outpatient care facilities
North America Prominent Market, Asia High Potential Region
North America is a potential market for molecular diagnostics kits used in the testing of
infectious diseases. This is due to technological advancements in molecular diagnostic tools, high
prevalence of infectious diseases, high patient awareness, and faster adoption of these devices
in the region. The near patient molecular solution market in Asia is projected to witness rapid
growth due to rampant research and development activities and growing awareness among the
populace about infectious diseases and their diagnostic procedures. Moreover, increase in
population and growing disposable income in developing countries such as India and China are
expected to boost growth of the near patient molecular solution market in the near future.
Report includes chapters which deeply display the following deliverable about industry :
• Near Patient Molecular solutions Market Research Objective and Assumption
• Near Patient Molecular solutions Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Near Patient Molecular solutions Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Near Patient Molecular solutions Market, By Regions
• Near Patient Molecular solutions Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Near Patient Molecular solutions Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Near Patient Molecular solutions Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Near Patient Molecular solutions Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Major companies operating in the global molecular diagnostics include Abbott
Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F.
Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., and GenMark
Inquire Here Before Purchase:
Near patient molecular solution market taxonomy
On the basis of technology, the near patient molecular solution market is segmented as follows:
PCR based: Idylla is a real-time PCR-based molecular diagnostic system designed in such a way
that physicians have fast access to highly reliable clinical molecular diagnostic information.
Treatments become more targeted to individual patient through personalized medicine.
Genetic Sequencing based: Platforms are available that enables genetic sequencing and
analysis of DNA data at point of care with high accuracy. Rapid DNA analysis is expected to gain
traction in the near future.
Hybridization based: Peptide nucleic acid (PNA) molecular beacon probe is used to quantify
16SrRNA of specific populations in RNA extract of environmental samples.
On the basis of application, the global near patient molecular solution market is segmented as
infectious diseases testing kits, pregnancy and fertility kits, hematology testing kits, urinalysis
testing kits, and glucose monitoring kits. Infectious disease kits are further sub-segmented into
tuberculosis, human immunodeficiency virus (HIV), hepatitis, and malaria.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]